PERCEIVED FAIRNESS OF DRUG-TESTING POLICIES: An Application of Leventhal's Principles of Procedural Justice.
- Published in:
- American Journal of Criminal Justice, 2002, v. 26, n. 2, p. 219, doi. 10.1007/BF02887828
- By:
- Publication type:
- Article
Works matching DE "CLINICAL drug trials -- Law %26 legislation"
Results: 26
1
2
What the paediatricians need--the launch of paediatric research in Europe.
- Published in:
- 2005
- By:
- Publication type:
- journal article
3
FDA to require suicide trials.
- Published in:
- Chemistry & Industry, 2008, n. 3, p. 6
- By:
- Publication type:
- Article
4
Investigational Sites in France.
- Published in:
- Applied Clinical Trials, 2000, v. 9, n. 11, p. 60
- By:
- Publication type:
- Article
5
Captive Subjects: Pharmaceutical Testing and Prisoners.
- Published in:
- Journal of Medical Toxicology, 2007, v. 3, n. 1, p. 37, doi. 10.1007/BF03161037
- By:
- Publication type:
- Article
6
The Food and Drug Administration's Role in the Use of Plastic Materials.
- Published in:
- Journal of Dental Research, 1966, v. 45, n. 6, p. 1675, doi. 10.1177/00220345660450061801
- By:
- Publication type:
- Article
7
New drug law to speed scientific review.
- Published in:
- 1992
- Publication type:
- Editorial
8
Good drug, bad luck: business, regulatory issues can create obstacles for drug development.
- Published in:
- 2004
- By:
- Publication type:
- journal article
9
Toward a Jurisprudence of Drug Regulation.
- Published in:
- Journal of Law, Medicine & Ethics, 2014, v. 42, n. 2, p. 244, doi. 10.1111/jlme.12139
- By:
- Publication type:
- Article
10
Reining in the Commercialized Foreign Clinical Trial.
- Published in:
- Journal of Legal Medicine, 2015, v. 36, n. 3/4, p. 367, doi. 10.1080/01947648.2015.1137505
- By:
- Publication type:
- Article
11
COLLABORATION AND TRANSPARENCY KEY TO MORE EFFECTIVE CLINICAL RESEARCH.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 3, p. 6
- By:
- Publication type:
- Article
12
FDA cracks down on labeling, initiates trial result reporting.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 11, p. 1203, doi. 10.1038/nbt1108-1203
- By:
- Publication type:
- Article
13
Gunvalson decision sends shockwaves through industry.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 11, p. 1201, doi. 10.1038/nbt1108-1201
- By:
- Publication type:
- Article
14
HDAC inhibitors overcome first hurdle.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 1, p. 17, doi. 10.1038/nbt0107-17
- By:
- Publication type:
- Article
15
U.S.: Priority reviews for medicines needed by armed forces.
- Published in:
- WHO Drug Information, 2018, v. 32, n. 1, p. 29
- Publication type:
- Article
16
Latest developments in pharmacovigilance.
- Published in:
- 2011
- Publication type:
- Proceeding
17
Review, Risk, Legality and Damages.
- Published in:
- European Journal of Risk Regulation, 2013, v. 4, n. 3, p. 399, doi. 10.1017/S1867299X00002701
- By:
- Publication type:
- Article
18
Regulatory Forum*.
- Published in:
- Toxicologic Pathology, 2016, v. 44, n. 8, p. 1069, doi. 10.1177/0192623316673201
- By:
- Publication type:
- Article
19
Highly lauded drug assessment program under attack.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2008, v. 179, n. 1, p. 26, doi. 10.1503/cmaj.080845
- By:
- Publication type:
- Article
20
Unlocking Health Canada's cache of trade secrets: mandatory disclosure of clinical trial results.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2012, v. 184, n. 2, p. 194, doi. 10.1503/cmaj.110721
- By:
- Publication type:
- Article
21
Congress Responds to the IOM Drug Safety Report--In Full.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
22
FDA Responds to Institute of Medicine Drug Safety Recommendations--In Part.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 17, p. 1917, doi. 10.1001/jama.297.17.1917
- By:
- Publication type:
- Article
23
A New Era of Unapproved Drugs.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
24
The methodological quality of three foundational law enforcement drug influence evaluation validation studies.
- Published in:
- Journal of Negative Results in Biomedicine, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1477-5751-12-16
- By:
- Publication type:
- Article
25
The application of human phase 0 microdosing trials: A systematic review and perspectives.
- Published in:
- Leukemia & Lymphoma, 2016, v. 57, n. 6, p. 1281, doi. 10.3109/10428194.2015.1101097
- By:
- Publication type:
- Article
26
Regulation and governance of multinational drug trials in stroke: barriers and possibilities.
- Published in:
- 2015
- By:
- Publication type:
- Other